NURO News and Press, NeuroMetrix Inc. From 12/24/20

SIFCO Industries (SIF) +54% on Q4 results.Creative Realities (CREX) +21%.Triterras (TRIT) +19%.AIM ImmunoTech (AIM) +17%.Bridgetown Holdings Limited (BTWN) +16%.Lightbridge Corporation (LTBR) +24% after nabbing patent in Eurasia for nuclear fuel assemblies.IZEA Worldwide (IZEA) +15%...

Atossa Therapeutics (ATOS) -42% on announcing pricing of $20M underwritten public offering.Pluristem Therapeutics (PSTI) -42% after DMC recommendation following interim analysis of its Phase III CLI study.Photronics PLAB -18% on Q4 earnings release.Talos Energy TALO -...

Gainers: Curis (CRIS) +335%.Lexicon Pharmaceuticals (LXRX) +97%.Mammoth Energy Services (TUSK) +61%.NeuroMetrix (NURO) +49%.Stitch Fix (SFIX) +45%.IGM Biosciences (IGMS) +38%.Blonder Tongue Laboratories (BDR) +26%.Infinity Pharmaceuticals (INFI) +25%.KLX Energy Services (KLXE) +24%....

Gainers: Curis CRIS +333%, Lexicon Pharmaceuticals LXRX +78%, NeuroMetrix (NURO) +73%,  Cancer Genetics, Inc. (CGIX) +25%, Cantel Medical CMD +17%.Losers: Obalon Therapeutics (OBLN) -19%, Arcturus Therapeutics Holdings ARCT -16%, ...

Curis CRIS +199% on encouraging CA-4948 data in leukemia.NeuroMetrix (NURO) +84%.Stitch Fix SFIX +39% on Q1 results.Lexicon Pharmaceuticals (LXRX) +31%.Cancer Genetics (CGIX) +28%.Smartsheet SMAR +18% on Q3 results.Tarena TEDU +18% on founder's going pr...

4 Penny Stocks Making Bigger Moves In December 2020 During COVID, trading penny stocks has been slightly different than in many years prior. While most stocks tend to trade based on some degree of speculation, penny stocks tend to be more speculative than most. This is due to th...

NeuroMetrix, Inc. (NURO) Q3 2020 Results Conference Call October 22, 2020 08:00 AM ET Company Participants Thomas Higgins - SVP & CFO Dr. Shai Gozani - President & CEO Conference Call Participants Jarrod Cohen - JM Cohen & Company Bill Church - TGRA Presentation Operator Good morn...

NeuroMetrix (NURO): Q3 net loss of 0.26M.Revenue of $2.03M (-3.3% Y/Y)Press Release For further details see: NeuroMetrix reports Q3 results

WOBURN, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chron...

WOBURN, Mass., Oct. 15, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 third quarter financial results before the opening of the market on October 22, 2020. The Company will host a conference call at 8:00 a.m., Eastern Time on Octobe...